Source:http://linkedlifedata.com/resource/pubmed/id/12519569
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2003-1-9
|
pubmed:abstractText |
Buprenorphine has recently been reported to be an alternative to methadone and LAAM for maintenance treatment of opioid dependent individuals, differing results are reported concerning its relative effectiveness indicating the need for an integrative review.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1469-493X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
CD002207
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12519569-Buprenorphine,
pubmed-meshheading:12519569-Humans,
pubmed-meshheading:12519569-Methadone,
pubmed-meshheading:12519569-Narcotic Antagonists,
pubmed-meshheading:12519569-Narcotics,
pubmed-meshheading:12519569-Opioid-Related Disorders,
pubmed-meshheading:12519569-Randomized Controlled Trials as Topic
|
pubmed:year |
2002
|
pubmed:articleTitle |
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
|
pubmed:affiliation |
National Drug and Alcohol Research Centre, University of New South Wales, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales, Australia, 2052. R.MATTICK@UNSW.EDU.AU
|
pubmed:publicationType |
Journal Article,
Review,
Meta-Analysis
|